Cite
Supplementary Figure 4 from A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer
MLA
Clare Y. Slaney, et al. Supplementary Figure 4 from A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-Cell Antitumor Effect Against Pancreatic Cancer. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5ee265cad79f9b4e9fa3df5a79596bbb&authtype=sso&custid=ns315887.
APA
Clare Y. Slaney, Michael H. Kershaw, Phillip K. Darcy, Ricky W. Johnstone, Belinda Lee, Yuchen Bai, Xin Du, Jack D. Chan, Amanda J. Oliver, Jian Kang, Daniela G.M. Tantalo, Aaron J. Harrison, Pilar M. Dominguez, Bianca von Scheidt, Minyu Wang, & Aesha I. Ali. (2023). Supplementary Figure 4 from A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer.
Chicago
Clare Y. Slaney, Michael H. Kershaw, Phillip K. Darcy, Ricky W. Johnstone, Belinda Lee, Yuchen Bai, Xin Du, et al. 2023. “Supplementary Figure 4 from A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-Cell Antitumor Effect Against Pancreatic Cancer,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5ee265cad79f9b4e9fa3df5a79596bbb&authtype=sso&custid=ns315887.